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Abstract. The influence of phosphorylation on the
binding of microtubule-associated protein 2 (MAP2)
to cellular microtubules was studied by microinjecting
MAP2 in various phosphorylation states into rat-1
fibroblasts, which lack endogenous MAP2. Conven-
tionally prepared brain MAP2, containing 10 mol of
endogenous phosphate per mol (MAP2-Plo), was com-
pletely bound to cellular microtubules within 2-3 min
after injection. MAP2 prepared in the presence of
phosphatase inhibitors, containing 25 mol/mol of
phosphate (MAP2-P25), also bound completely. How-
ever, MAP2 whose phosphate content had been re-
duced to 2 mol phosphate per mol by treatment with
alkaline phosphatase in vitro (MAP2-P2) did not ini-
tially bind to microtubules, suggesting that phosphory-
lation of certain sites in MAP2 is essential for binding
M
1CROTUBULE-associated protein 2 (MAP2)' is the
major accessory component of brain microtubules.
The high molecular weight form of MAP2, with
which this study is concerned, is selectively localized in neu-
ronal dendrites (Bernhardt and Matus, 1984; Caceres et al .,
1984; Burgoyne and Cumming, 1984 ; Decamilli et al .,
1984), where it is believed to contribute to the extended and
cylindrical form ofthese processes by stimulating tubulin po-
lymerization and binding to and cross-linking microtubules
(Mates, 1988).
Phosphorylation of MAP2 affects both the potency with
which it stimulates tubulin polymerization and its affinity for
tubulin polymers in vitro (Jameson and Caplow, 1981; Mur-
thy and Flavin, 1983 ; Burns et al., 1984), suggesting that the
state of MAP2 phosphorylation might modulate its interac-
tion with microtubules in vivo. There have, however, been
very few studies of the relationship between MAP2 and
microtubules in living cells, and none of these have ad-
dressed the question ofphosphorylation state. One approach
has been to microinject MAP preparations, enriched in
MAP2, into fibroblasts that do not express endogenous
1. Abbreviation used in this paper: MAP2, microtubule-associated pro-
tein 2 .
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to microtubules. MAP2-P10 was further phos-
phorylated in vitro via an endogenously bound protein
kinase activity, adding 12 more phosphates, giving a
total of 22 mol/mol. This preparation (MAP2-P10112)
also did not bind to microtubules. Assay of the bind-
ing of these preparations to taxol-stabilized tubulin
polymers in vitro confirmed that their binding to tubu-
lin depended on the state of phosphorylation, but the
results obtained in microinjection experiments differed
in some cases from in vitro binding. The results sug-
gest that the site of phosphate incorporation rather
than the amount is the critical factor in determining
microtubule binding activity of MAP2 . Furthermore,
the interaction of MAP2 with cellular microtubules
may be influenced by additional factors that are not
evident in vitro.
MAP2 and then localize the MAP2 by immunofluorescence.
In two studies of this type, all the injected MAP2 was found
to bind to the cellular microtubules (Scherson et al., 1984;
Olmsted et al., 1989) . In contrast, an immunocytochemical
study of endogenous MAP2 distribution in cultured primary
neurons showed that it was not colocalized with tubulin poly-
mers but was distributed throughout the cytoplasm (Mates
et al., 1986).
A potential explanation of these differences lies in the
phosphorylation stateof native MAP2 in nervecellsgrowing
in culture compared to biochemically isolated MAP2 prepa-
rations used in microinjection experiments. Available data
suggests that the phosphate content of MAP2 decreases
significantly during its isolation from brain (Tsuyama et al.,
1987). Our experiments were therefore designed to test the
influence of phosphorylation state of MAP2 on its binding
to microtubules in living cells. We compared MAP2 in four
states of phosphorylation: (a) as obtained from brain; (b) as
obtained from brain in the presence of phosphatase inhibi-
tors ; (c) after enzymatic dephosphorylation in vitro; and (d)
after additional in vitro phosphorylation. MAP2 in each of
these phosphorylation states was purified chromatographi-
cally then injected into fibroblastic cells, and the relationship
ofthe MAP2 to the cellular microtubules was determined by
735immunofluorescence staining. These experiments reveal that
these four distinct phosphorylation states significantly in-
fluence the interaction of MAP2 with cellular microtubules.
Materials andMethods
Cell Culture
Rat-1 fibroblasts were cultured in DME (GIBCO, Renfrewshire, Scotland)
supplemented with 10% FCS. For some experiments "serum-starved" cells
were maintained in the same medium without serum for 12 h before begin-
ning the experiment.
Preparation ofMAP2
MAP2 was prepared either from repolymerized microtubules or directly
from brain supernatant. Microtubules were prepared from adult rat brain
by three cycles of repolymerization as described by Karr et al. (1979). To
obtainmicrotubules with minimal dephosphorylation of MAPS, brains were
removed from individual animals and immediately homogenized in micro-
tubule assembly buffer (0.1 M MES, pH 6.4, 2 mM EGTA, and 1 mM
M9C12) containing the phosphatase inhibitors sodium fluoride (20 mM)
and sodium pyrophosphate (10 mM). The homogenates were collected at
ice temperature and then centrifuged for 45 min at 4°C at 100,000 g. To
obtain heat-stable MAPS from either recycled microtubules or brain super-
natant, the preparations were made up to 0.75 M NaCl and 2 mM DTT,
boiled for 5 min, and then centrifuged at 100,000 g for 60 min (Fellows et
al., 1977). These preparations were concentrated to 10 mg protein per ml
using Centricon 30 microconcentrators (Amicon, Zurich) and the MAPS
were fractionatedby gel filtration chromatography on a Superose 6 column
(Pharmacia, Diibendorf) in microtubule assembly buffer containing 0.3 M
KCI. The MAPcontentof fractions was assayed by immobilizing0.5 pl dots
on nitrocellulose and staining for MAP2, MAP3, taw, and tubulin with
mAbs. The major MAP2peakwas collected and concentrated using Centri-
con 30 ultrafiltration. The purified proteins at 5 mg/nil were stored as ali-
quots at -70°C until required for microinjection.
Enzymatic Dephosphorylation ofMAP
Heat-stable MAPS (5 mg/ml) were treated with calf intestinal phosphatase
in buffer containing 0.1 M Tris HCI, pH 8.4, 1 MM M9C12, 1 mM EGTA,
1 mM EDTA, 2 mM PMSF, 1 wg/ml pepstatin, 1 U/nil aprotinin, and 0.1
mM ZnC12 for 12 h at 37°C (Tsuyama et al., 1986; Selden and Pollard,
1983) . From a range of commercial preparations tested, only that from
Boehringer (Mannheim) (cat.1t713-023, 25 U/ml) combined good phospha-
tase activity with lack of detectable proteolytic activity toward MAPs.
Nevertheless, protease inhibitors were used in all experiments. To achieve
maximal dephosphorylation, fresh phosphatase was added to the reaction
every 3 h to a final concentrationof 100 U/ml. The phosphatase was subse-
quently inactivated by heating for 2 min in a boiling water bath.
In Vitro Phosphorylation ofMAP2
MAP2 was phosphorylated via endogenous bound kinase activity essen-
tially as described by Burns et al. (1984). Microtubule proteins (5 mg/ml)
were phosphorylated in a buffer containing 0.1 M MES, 20 mM sodium
fluoride, 2.5 mM EGTA, 0.5 M MgSO4, 0.1 mM EDTA, 0.1 mM DTT, 20
PM GTP, and 500,uM ATP for 30 min at 37°C. The reaction was stopped
by adding NaCl to 0.75 M and heating in a boiling water bath for 5 min.
Thephosphate contentsofpurified MAP2 samples weredetermined accord-
ing to Selden and Pollard (1983).
Gel Electrophoresis and Immunoblotting
4-14% linear gradient SDS-polyacrylamide electrophoretic gel were run ac-
cording to Laemmli (1970). Proteins were transferred to nitrocellulose elec-
trophoretically (Towbin et al., 1979), visualized by staining with 2% Pon-
ceau red in 3% perchloric acid, and destaining with 10% acetic acid. The
stain was washed out with 100 mM (PBS 150 mM NaC12, pH 7.2) and the
blots were immunostained using mAbs (Towbin et al., 1979).
Microinjection Procedure
Purified MAP2 was microinjected into rat-1 cells in assembly buffer con-
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taining 0.3 M KCI (Scherson et al., 1984) through glass capillary needles
at constant pressure. The cells were plated at a density of 2 x 104
cells/cm2 in 35-mm tissue culture dishes containing a finder grid pattern
and grown for 24 h. During microinjection the culture medium contained
10 mM Hepes buffer, pH 7.2, and the culture dish was maintained at 37 t
0.5°C using an aluminium block thermostat fixed on the microscope stage.
The amount of MAP2 injected was assessed visually using the phase-
contrast optics of a Zeiss IM-35 inverted microscope (Zeiss, Zilrich) at
x250 magnification and was controlled by the length of time that the tip
remained inside the cell. The injected volume varied from 1 to 10% ofthe
cell volume. In each experiment cells were injected at 30-s intervals, so that
at the time of fixation a series ofcells representing a0-30-min time course
of postinjection survival were present in the same dish.
Immuno,fluorescent Labeling ofCultured Cells
Cells were rinsed with PBS, fixed with 3% paraformaldehyde in PBS for
30 min at room temperature, and permeabilized by treatment with 0.05%
Triton X-100 in PBS for 10 min. Nonspecific binding sites were blocked
by treatment for 10 min with 5% FCS in PBS, and the cells then incubated
overnight with a 1:50 dilution of rabbit antiserum against tubulin (Poly-
science, Ulmenhof, West Germany) and AP14 mAb against MAP2 (Ca-
ceres et al., 1984) at 4°C. After washing, the cells were incubated for 2 h
at room temperature with fluorescein-labeled goat anti-rabbit IgG and
rhodamine-labeled goat antimouse (Nordic, Biogenzia Lemania, Lausanne)
each diluted 1:200 and observed in a Zeiss Universal fluorescence micro-
scope.
In Vitro BindingAssay
The binding of MAP2 in various states of phosphorylation to taxol-
stabilized tubulin polymers was assayedas described by Bums et al. (1984).
Tubulin was purified from recycled microtubules as described by Hamel and
Lin (1981) and concentrated in assembly buffer (Karr et al., 1979) using
Centricon 30 microconcentrators. Assay samples consisted of purified
MAP2 and tubulin in a molar ratio of 1:12. They were brought to various
concentrations of NaCl as required, incubated with taxol (20 ,UM ; Vallee,
1982) for 15 min at 37°C, and pelleted in an Airfuge (Beckman, Geneva).
The pellets were resuspended in sample buffer and separatedby electropho-
resis in 7% SDS-polyacrylamide gels (Laemmli et al., 1970). These were
stained with Coomassie brilliant blue and the relative protein contents of
the bands was determined as peak heights measured in a Shimadzu reflec-
tance scanner (Burkhardt Instruments, Zurich). To account for minor varia-
tions in the amount of tubulin the MAP2 measurements for each sample
were normalized using the peak heights of the tubulin band taken from the
same scan.
Results
Preparation ofMAP2 with Different Levels
ofBound Phosphate
To distinguish the four different phosphorylation states of
MAP2 studied in these experiments, we used a designation
of the type MAPP,o, where the subscript number indicates
the average number of bound phosphates per mol of MAP2
in that particular preparation.
MAP2 prepared from conventional recycled microtubule
preparations or directly from rat brain supernatant (Sl) in
absence of phosphatase inhibitors has about 10 covalently
bound phosphates per molecule (MAP2-P,o; Table 1). This
represents only part of the phosphate content of the native
molecule because MAP2 is rapidly dephosphorylated during
this conventional preparation procedure (our unpublished
observations, see also Murthy and Flavin, 1983; Tsuyama et
al., 1987). To obtain MAP2 with more of the endogenous
phosphate intact, we isolated it directly from brain superna-
tant in presence of phosphatase inhibitors and this, in con-
junction with rapid processing during the initial steps,
yielded MAP2 with a phosphate level of ti25 mol of cova-
lently bound phosphate per mol (MAP2-P25; Table 1). To
736Table I. Phosphate Content ofMAP2 After Different Preparation Methods
MAP2 purification from :
assess further the role ofphosphorylation, we dephosphory-
lated MAP2-P, o enzymatically. Maximal dephosphoryla-
tion (see Materials and Methods) reduced the MAP2 phos-
phate content to 2 mol/mol (MAP2-P2 ; Table I) . Finally,
we also conducted experiments with MAP2 that had been
phosphorylated in vitro via a copurifying kinase activity
(Vallee et al ., 1981 ; Bums et al ., 1984) . This resulted in the
additional incorporation of up to 12 phosphates into MAP2-
P,o, yielding MAP2 with 22 mol of covalently bound phos-
phate (MAP2-Pao+12 ; Table n .
MAP2 in these various phosphorylation states was purified
from the mixture ofheat-stable MAPS by gel filtration chro-
matography and the MAP2-containing fractions were iden-
tified and their purity analyzed by immunodot assay (Fig. 1
A), after which theMAP2 fractions were collected, concen-
trated, and their purity and freedom from degradation con-
firmed by SDS-PAGE (Fig . 1 B) .
Microinjection Experiments
Rat-1 fibroblast cells have two advantages as recipient cells
Figure 1 . MAP2 purification . Heat-stable MAPS were fractionatedon a Superose 6 column, and the contents ofeach fraction was established
by immunodot assay (A) using mAbs againstMAP2, MAP3, Tau, and Tubulin (TU) . The MAP2 fractions were collected, concentrated,
and analyzed by SDS-PAGE (B) : (lane A) supernatant fraction from brain ; (lane B) thrice-cycled brain microtubules ; (lane C) heat-stable
brain MAPS ; (lane D) purified MAP2 .




for MAP2 microinjection . First, as is evident from nonin-
jected cells in Figs. 2-6, they do not express detectable levels
of MAP2, a necessary condition if microinjected MAP2 is
to be unambiguously identified . Secondly, these cells pos-
sess only a moderate density of cytoplasmic microtubules
whose distribution can be resolved clearly by immunofluo-
rescence staining with antitubulin . The results described are
based on observations of several hundred cells from more
than 50 individual cultures into which samples from 3 differ-
ent preparations of purified MAP2 in each phosphorylation
state were microinjected . The same results were obtained in
all cases .
Intracellular Distribution ofMicroinjectedMAP2
MAP2 in Either of Two Endogenous Phosphorylation
States Binds to Cellular Microtubules. When MAP2-P,o
(i.e., conventionally prepared MAP2) was injected into Rat-1
cells it initially diffused throughout the cytoplasm (Figs. 2
b and 3 b) . However, by 3 min after injection it had started
to bind to microtubules (Figs . 2 d and 3 d), and by 5 min
MAP2-Pao : Twice-cycled rat brain microtubules in the absence of phosphatase inhibitors 9.8 t 0.65
MAP2-P25 : Boiled rat brain supernatant (S1) in presence of phosphatase inhibitors 24.6 t 2.3
(NaF, Na 4P20,)
MAP2-P2 : Boiled rat brain supernatant dephosphorylated by alkaline phosphatase 2.2 t 0.4
MAP2-P,o+i2 : Microtubules phosphorylated in vitro by cAMP-independent protein kinase 21 .3 t 1.8
(Burns et al ., 1984)Figure 2 . Intracellular localization of tubulin andmicroinjectedMAP2 prepared in absence of phosphatase inhibitors (MAP2-P,o) in rat-1
cells . 'Ihbulin (a, c, and e) andMAP2 (b, d, andf) were simultaneously detected in thesame cell cultures by staining with mousemonoclo-
nalanti-MAP and rabbit polyclonal antitubulin followed by rhodamine-labeled antimouse and fluorescein-labeled anti-rabbit IgGs . In this
figure and Figs. 3-6, microinjected cells are identified in the antitubulin-stainedimages by asterisks . MAP2 is not bound to microtubules
after 2 min (a and b), is partially bound after 3-4 min, binds to microtubules (c and d), and decorates all the microtubules present in
the cell after 15 min (e andf) . Bar, 10 lm .
after injection all the detectable MAP2 was associated with
microtubules and this continued to be the case until 30 min
after injection, the longest postinjection time tested . Figs . 3
fand 4fshow this at 15 minpostinjection . The same results
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were obtained when MAP2 prepared in the presence of
phosphatase inhibitors (MAP2-P25) was injected (data not
shown) .
738Figure 3 Detail of the intracellular localization of MAP2-P,o at
various times after microinjection. Other than the higher mag-
nification the conditions were the same as in Fig . 2 . Bar, 1 gm .
Enzymatically DephosphorylatedMAP2Does Not Bind
to Micrtubules . Each batch of dephosphorylated MAP2
(MAP2-P2) was examined by SDS-PAGE to confirm that it
had not been degraded by treatment with alkaline phospha-
tase . As a further control in all dephosphorylation experi-
ments, an additional sample of the starting preparations
(MAP2-P, 0) was incubated in the same buffer and under the
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same conditions, but without the addition of enzyme . This
controlMAN was microinjected into Rat-1 cells and it was
confirmed that it bound to cellular microtubules . The de-
phosphorylated MAN (MAP2-P2 ) showed a different pat-
tem of behavior. Like the control MAP2-P, o it was initially
distributed throughout the cytoplasm after injection (Fig . 4
b) . However, with MAP2-P2 this condition persisted longer
than in the previous cases and after 4 min it still showed no
binding to microtubules (Fig . 4 d) . Only after 15 min did
some binding of injected cells MAP2-P2 to microtubules in
the periphery of the cell become visible, but large amounts
still remained spread throughout the cytoplasm (Fig . 4 f) .
We considered the possibility that this delayed binding of
dephosphorylated MAP2 to microtubules might reflect a
slow rephosphorylation by cellular protein kinases ofcertain
sites on the molecule that are essential for microtubule bind-
ing . To test this hypothesis we injected dephosphorylated
MAP2 into cells that had been serum starved for 24 h when
protein kinase activities andMAP phosphorylation levels are
lower (Shaw et al ., 1988) . The result of this experiment was
that the injected MAP2-P2 remained spread throughout the
cytoplasm and did not bind to microtubules even after 30
min (Fig . 5 b) . To eliminate the possibility that this lack of
binding might be the result of some change in the microtu-
bules (i.e., the tubulin polymers) induced by the serum-free
conditions, we injected highly phosphorylated MAP2-P25
into the serum-starved cells . In this case the MAP2-P2,
bound normally to the microtubules (Fig. 5 d) .
In Vivo and In Vitro Phosphorylation ofMAP2 Have
Different Effects . The above experiments indicated that
phosphorylation ofMAP2 promotes its binding to microtu-
bules . This result is at first sight contradictory to previous
studies in which the phosphorylation ofMAP2 was found to
decrease both its tubulin polymerization promoting activity
(Jameson and Caplow, 1981) and its affinity for microtubules
(Bums et al., 1984) . However, in these earlier experiments
the phosphorylation ofMAP2 was carried out in vitro using
endogenous kinase activity that copurifies with MAP2 (Slo-
boda et al ., 1975 ; Vallet et al., 1981) . This suggested to us
that there might be two different states of MAP2 phosphor-
ylation, an endogenous neuronal state that, as the above
experiments show, is necessary forMAP2 binding to micro-
tubules and a second, in vitro phosphorylation state, that
lowers the affinity ofMAP2 for microtubules . To test this hy-
pothesis we took MAP2 prepared by conventional means
(MAP2-Pto) and phosphorylated it in vitro via the bound
kinase activity. This introduced 12 extra bound phosphates
into the molecule (MAP2-P,,,2, Table I) . When injected
into cells, this in vitro phosphorylated MAP2 did not bind
to microtubules even after 30 min (Fig. 6) . As a control,
MAP2-P, o was incubated in the same buffer under the same
conditions, but without the addition ofATP When this con-
trol preparation was injected into cells it bound to microtu-
bules .
In Vitro Binding ofMAP2 in Different Phosphorylation
States to Taxol-stabilizedMicrtubules. Fig . 7 shows assays
ofthe in vitro tubulin-binding capacity ofMAP2 in each ofthe
four phosphorylation states . In the presence of increasing
salt concentrations the preparations bound to taxol-stabilized
microtubules with different affinities that broadly reflected
their binding to cellular microtubules, with the two prepara-
tions that do not bind to cellular microtubules (MAP2-P2
739Figure 4. Dephosphorylated MAP2 (MAP2-P2) shows reduced binding to microtubules . MAP2-P2 does not bind to microtubules 2 or 4
min after microinjection (b and d) . Only after 15 min is any colocalization with tubulin filaments detectable (e and f), and even then
a substantial portion of MAP2-P2 remains cytosolic (e and f) . Bar, 10 um .
and MAP2-P,o+,2) binding less strongly than the two prepa-
rations (MAP2-Plo and MAP2-P25) that do bind . The re-
sults we obtained for MAP2-P,o and MAP2-P, 0+12 are close-
ly comparable to those previously reported (see Burns et al .,
1984, Fig . 1) .
An interesting feature of the results is that although the
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binding performance of MAP2-P25 and MAP2-P,o+,2 in vitro
was not very different, in microinjection experiments the
former appears completely bound to cellular microtubules,
but the latter not at all, suggesting that in living cells phos-
phorylation of MAP2 has a greater effect on its binding to
microtubules than can be detected in vitro . It is also worth
740Figure S . In serum-deprived cells, dephosphorylated MAP2 (MAP2-P2 ) does not bind to microtubules even 30 min after microinjection
(a and b) . c and d show a control serum-deprived cell microinjected with MAP2-P25, which under the same conditions is already bound
to microtubules after 4 min . Bar, 10 Am.
mentioning that we saw a small but consistent difference in the
elution of MAP2-P25 and MAP2-P, o from taxol-stabilized
microtubules, even thoughwe observed no difference in their
binding to cellular microtubules after microinjection .
Discussion
Different Phosphorylation Sites in
MAP2Have Distinct Effectson Its Interaction
with Cellular Microtubules
Our results show thatMAP2 can exist in at least four distinct
states of phosphorylation that differently influence its binding
to microtubules in living cells . Two of these, with phosphate
contents of25 or 10 mol/mol, are endogenously phosphor-
ylated states that bind effectively to cellular microtubules.
The other two, enzymatically dephosphorylatedMAP2 con-
taining 2 mol/mol ofphosphate, and in vitro phosphorylated
MAP2 containing 22 mol/mol of phosphate, show no ap-
preciable binding to cellular microtubules.
The lack of binding to cellular microtubules by MAP2 af-
ter dephosphorylation is correlated with a reduction in its
binding to taxol-stabilized microtubules in vitro . The fact
that it retains some in vitro binding activity indicates that its
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failure to bind to microtubules in cells is not merely the re-
sult ofdenaturation caused by theenzyme treatment . Further
evidence in favor ofthis interpretation is that when dephos-
phorylated MAP2 is injected into actively growing cells
it slowly regains microtubule binding capacity. The reap-
pearance of microtubule binding activity suggests that the
dephosphorylated MAP2 undergoes rephosphorylation by
protein kinases in the recipient fibroblast cells . This inter-
pretation is supported by the observation that the reemer-
gence ofmicrotubule binding is not seen in quiescent serum-
starved cells, where kinase activity is low (Shaw et al ., 1988) .
Thus, one or more ofthe 10 mol of endogenous bound phos-
phates present in conventionally prepared MAP2 appear to
be essential for its binding to microtubules .
MAP2 phosphorylated in vitro via its endogenously bound
kinase activity (Sloboda et al ., 1975 ; Vallee et al, 1981) also
shows reduced affinity for microtubules in vitro (Murthy and
Flavin, 1983 ; Burns et al ., 1984 ; this study), which corre-
lates with its lack of binding to microtubules in living cells.
It is striking that MAP2 phosphorylated in vitro contains 22
mol/mol ofphosphate and does not bind to cellular microtu-
bules, whereasMAP2 purified from brain in the presence of
phosphatase inhibitors contains more phosphate (25 mol/
mol) and binds strongly. Also the difference in microtubule
74 1Figure 6. Intracellular localization of microinjected MAP2 that had been phosphorylated in vitro via the endogenously bound kinase
(MAP2-P,o+1z)- It did not bind to microtubules during the entire experimental period . (a and b, 4 min; c and d, 30 min) . Bar, 10 jm .
[ NcCI ] Mol
Figure 7 . Binding of MAP2 in different states of phosphorylation
to taxol-stabilized microtubules in vitro at increasing concentra-
tions of NaCl . Standard errors for the results of three separate ex-
periment are indicated. MAP2-P,o (o--o) ; MAP2-P25
MAP2-Pio+i2 (o-o) ; MAP2-P2
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binding affinity of these two forms in vitro, while distinct,
is not great . These observations indicate that it is not the
level of phosphorylation that is important in determining
binding of MAP2 to microtubules in cells, but some other
quality of the phosphorylated state, most likely the location
of the phosphorylated sites within the molecule .
There is very little data on the precise location of endoge-
nous phosphorylation sites in MAP2 . Both cAMP-dependent
and Cal+/calmodulin kinases have been shown to phos-
phorylate sites in the portion of the molecule that is bound
to microtubules (Vallee, 1980 ; Schulman, 1984 ; Vallano et
al ., 1985 ; Hernandez et al., 1987) . However, it is clear that
the degree of phosphorylation of all in vitro preparations is
less than that ofMAP2 in the living brain (Tsuyama et al.,
1987), and other phosphorylation sites might exist that also
influence the interaction ofMAP2 with microtubules . This
possibility is suggested by experiments showing that various
well-characterized kinases phosphorylate different sites on
MAP2 in vitro (Hernandez et al ., 1987) and that at least
some MAP2 sites endogenously phosphorylated in the brain
differ from those phosphorylated by identified kinases in
vitro (Murthy et al., 1985) .
Phosphorylation ofMAP2MayBe Required
for Microtubule Binding
The microtubule binding site ofMAP2 has been localized to
742a region near the C0011-terminus of the molecule contain-
ing 3 imperfectly repeated 18 amino acid sequences (Lewis
et al., 1988). Synthetic oligopeptides based on the second of
these sequences, m2 (Joly et al., 1989), can bind to tubulin
in vitro, showing that phosphorylation is not necessary for
the interaction between the MAP2 binding site and tubulin.
Why then, in our experiments, was dephosphorylation cor-
related with a decrease in MAP2 affinity for microtubules
both in vitro and in cells? The answer is probably that our
experiments used the whole MAP2 molecule, of which the
m2 sequence represents only 18 amino acids out of 1,828.
Other parts ofthe MAP2 molecule may influence the affinity
ofthe binding domain, for example, by folding in such a way
as to occlude it, and this folding may in turn be influenced
by phosphorylation at sites in the molecule remote from the
microtubule-binding domain.
The Fbtential Influence ofMAP2 Phosphorylation
on Neuronal Morphology
In addition to stabilizing tubulin polymers, MAP2 is also a
component of fine filamentous cross-bridges between neu-
ronal microtubules (Hirokawa et al., 1988). Transfection ex-
periments, in which MAP2 was expressed in nonneuronal
cells from cloned cDNA, show that it can induce the bun-
dling of microtubules (Lewis et al., 1989). Changes in the
affinity of MAP2 for tubulin, resulting from changes in the
phosphorylation state, would therefore influence not only the
stability of microtubules, but also the fasciculation of den-
dritic microtubules, which is essential for the maintenance
of the axial symmetry of neuronal processes (Matus, 1988).
Aoki and Siekevitz (1985) found that a marked change oc-
curs in MAP2 phosphorylation at the end of the critical
period in the cat visual cortex. A compelling aspect of their
results is that when the critical period was prolonged by rais-
ing animals in the dark, the change in MAP2 phosphoryla-
tion was delayed in parallel. Furthermore, both the end of
the critical period and the change in phosphorylation could
be induced by a short exposure of the dark-reared animals
to light. Recently, Halpain and Greengard (1990) have shown
that stimulation ofNMDAclass glutamate receptors in brain
slices induces net dephosphorylation of MAP2. Taken to-
gether with our results, these data suggest that changes in
MAP2 phosphorylation, triggered by sensory inputs to the
nervous system, may influence the stability of the microtubu-
lar network and hence regulate the anatomical plasticity of
neuronal dendrites in the developing brain.
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